Financials

  • Market Capitalization 53.04 M
  • Employee 17
  • Founded 2018
  • CEO N/A
  • Website www.instilbio.com
  • Headquarter New York, United States
  • FIGI BBG00ZGYN521
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.18
ratio cours/chiffre d'affaires
6.16

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4253
BYSI
BeyondSpring, Inc. - Ordinary Shares
1.33 USD0.00%-18.90%-17.39%-41.41%54.69 M USD
4261
INMB
INmune Bio Inc. - Common stock
2.02 USD+8.60%+16.09%+56.59%-1.94%53.70 M USD
4272
XLO
Xilio Therapeutics, Inc. - Common Stock
9.03 USD-2.27%-1.20%+6.24%+1136.99%52.22 M USD
4279
MCRB
Seres Therapeutics, Inc. - Common Stock
5.34 USD-4.98%-32.49%-5.32%-35.12%51.19 M USD

Nouvelles